KBKishore K. Bhakoo

Kishore K. Bhakoo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kishore K. Bhakoo has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Blocki

    Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China

    2 shared publications
  • Anna Goralczyk

    Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore, Singapore; NUS Tissue Engineering Programme, Life Sciences Institute, National University of Singapore, Singapore

    2 shared publications
  • Jean-Yves Dewavrin

    NUS Graduate School for Engineering and Integrative Sciences (NGS), National University of Singapore, Singapore; Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore, Singapore; NUS Tissue Engineering Programme, Life Sciences Institute, National University of Singapore, Singapore

    2 shared publications
  • Priscilla Peh

    Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore, Singapore; NUS Tissue Engineering Programme, Life Sciences Institute, National University of Singapore, Singapore

    2 shared publications
  • Sebastian Beyer

    Federal Institute for Materials Research and Testing (BAM), Berlin 12485, Germany

    2 shared publications
  • Yingting Wang

    NUS Graduate School for Engineering and Integrative Sciences (NGS), National University of Singapore, Singapore; Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore, Singapore; NUS Tissue Engineering Programme, Life Sciences Institute, National University of Singapore, Singapore

    2 shared publications

Latest Publications

  • nCP:Fe—A Biomineral Magnetic Nanocontrast Agent for Tracking Implanted Stem Cells in Brain Using MRI

    by Ida M. Anna, Binulal N. Sathy, Anusha Ashokan, Genekehal Siddaramana Gowd, Ranjith Ramachandran, Ayalur Kodakara Kochugovindan Unni, Maneesh Manohar, DeepthiMol Chulliyath, Shantikumar Nair, Kishore Bhakoo, et al.

    In vivo tracking of transplanted stem cells to monitor their migration, biodistribution, and engraftment in the host tissue is important for assessing the efficacy of stem cell therapeutics. Here, we report a biomineral nanocontrast agent, iron doped calcium phosphate nanoparticles (nCP:Fe), for the in vivo tracking of stem cells in brain using magnetic resonance imaging (MRI). We have synthesized ∼100 nm sized nCP nanoparticles doped with 9.81 wt % Fe3+. In vitro studies using mesenchymal stem cells (MSCs) showed excellent biocompatibility for nCP:Fe with ∼87% labeling efficiency under optimized conditions (100 μg/mL, 6 h). Most importantly, the labeling was not found to affect the neurogenic differentiation potential of MSCs. MRI of labeled cells (∼22.34 pg Fe/cell) showed significant reduction in T2 relaxation time from 195 to 89 ms, rendering dark contrast. In vivo transplantation of labeled cells (1 × 106 cells) in external capsule of healthy rat brain showed a clearly distinguishable hypointense (dark) region in T2 weighted MR images, which remained visible up to 30 days. Subsequently, MRI tracking of labeled MSCs transplanted intracerebrally, 3 mm near to the LPS induced inflammatory site in brain, showed successful migration of labeled MSCs toward the site of inflammation. The cell migration was confirmed ex vivo by Prussian-blue (Fe3+) and Alizarin-red (Ca2+) staining of tissue sections, where individual cells were found migrated to the site of inflammation over a period of 30 days. In summary, our results clearly show that, as a biocompatible mineral composition, nCP:Fe is a promising magnetic nanocontrast agent for MRI based cell tracking in vivo.


  • Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy

    by Sakthivel Sekar, Joanes Grandjean, Joanne Fv. Garnell, Roland Willems, Hilde Duytschaever, Sankar Seramani, Huang Su, Luc Ver Donck, Kishore K. Bhakoo


  • Open Access

    MRI detection of endothelial cell inflammation using targeted superparamagnetic particles of iron oxide (SPIO)

    by Joyce M. S. Chan, Maggie S. H. Cheung, Richard G. J. Gibbs, Kishore K. Bhakoo

    Background: There is currently no clinical imaging technique available to assess the degree of inflammation associated with atherosclerotic plaques. This study aims to develop targeted superparamagnetic particles of iron oxide (SPIO) as a magnetic resonance imaging (MRI) probe for detecting inflamed endothelial cells.Methods: The in vitro study consists of the characterisation and detection of inflammatory markers on activated endothelial cells by immunocytochemistry and MRI using biotinylated anti‐P‐selectin and anti‐VCAM‐1 (vascular cell adhesion molecule 1) antibody and streptavidin conjugated SPIO.Results: Established an in vitro cellular model of endothelial inflammation induced with TNF‐α (tumor necrosis factor alpha). Inflammation of endothelial cells was confirmed with both immunocytochemistry and MRI. These results revealed both a temporal and dose dependent expression of the inflammatory markers, P‐selectin and VCAM‐1, on exposure to TNF‐α.Conclusion: This study has demonstrated the development of an in vitro model to characterise and detect inflamed endothelial cells by immunocytochemistry and MRI. This will allow the future development of contrast agents and protocols for imaging vascular inflammation in atherosclerosis. This work may form the basis for a translational study to provide clinicians with a novel tool for the in vivo assessment of atherosclerosis.


  • Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium

    by Anna Blocki, Sebastian Beyer, Jean-Yves Dewavrin, Anna Goralczyk, Yingting Wang, Priscilla Peh, Michael Ng, Shehzahdi S. Moonshi, Susmitha Vuddagiri, Michael Raghunath, et al.


  • Open Access

    Sourcing of an Alternative Pericyte-Like Cell Type from Peripheral Blood in Clinically Relevant Numbers for Therapeutic Angiogenic Applications

    by Anna Blocki, Yingting Wang, Maria Koch, Anna Goralczyk, Sebastian Beyer, Nikita Agarwal, Michelle Lee, Shehzahdi Moonshi, Jean-Yves Dewavrin, Priscilla Peh, et al.


  • A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection

    by Kaili Ji, Wee Siang Lim, Sam Fong Yau Li, Kishore Bhakoo

    Aptamers are single-stranded oligonucleotides that are capable of binding wide classes of targets with high affinity and specificity. Their unique three-dimensional structures present numerous possibilities for recognizing virtually any class of target molecules, making them a promising alternative to antibodies used as molecular probes in biomedical analysis and clinical diagnosis. In recent years, cell-systematic evolution of ligands by exponential enrichment (SELEX) has been used extensively to select aptamers for various cell targets. However, aptamers that have evolved from cell-SELEX to distinguish the “stimulus-response cell” have not previously been reported. Moreover, a number of cumbersome and time-consuming steps involved in conventional cell-SELEX reduce the efficiency and efficacy of the aptamer selection. Here, we report a “two-step” methodology of cell-SELEX that successfully selected DNA aptamers specifically against “inflamed” endothelial cells. This has been termed as stimulus-response cell-SELEX (SRC-SELEX). The SRC-SELEX enables the selection of aptamers to distinguish the cells activated by stimulus of healthy cells or cells isolated from diseased tissue. We report a promising aptamer, N55, selected by SRC-SELEX, which can bind specifically to inflamed endothelial cells both in cell culture and atherosclerotic plaque tissue. This aptamer probe was demonstrated as a potential molecular probe for magnetic resonance imaging to target inflamed endothelial cells and atherosclerotic plaque detection. The cells are activated with stimulus and incubated with single-stranded DNA library. The sequences bound on the activated cells are released and amplified to incubate with naïve cells without stimulation. The sequences unbound to the naïve cells are then incubated with activated cells again and go into the next round of selection. After the selection reaches the end point, the single-stranded DNA collected from the last round is cloned and sequenced for identification


  • Single-Phase Dy2O3:Tb3+Nanocrystals as Dual-Modal Contrast Agent for High Field Magnetic Resonance and Optical Imaging

    by Gautom Kumar Das, Yan Zhang, Loyola D’sIlva, Parasuraman Padmanabhan, Boon Chin Heng, Joachim Say Chye Loo, Subramanian Tamil Selvan, Kishore K. Bhakoo, Timothy Thatt Yang Tan


  • In vivostem cell tracking in neurodegenerative therapies

    by Kishore Bhakoo

    Introduction: Cell transplants to replace cells lost due to injury or degenerative diseases, for which there are currently no cures, are being pursued in a wide range of experimental models. Thus, the application of stem cell-based therapies to treat neurodegenerative and traumatic injuries is now a clinical reality. However, the monitoring of cellular grafts, non-invasively, is an important aspect of the ongoing efficacy and safety assessment of cell-based therapies. Hence, there is a need for non-invasive imaging techniques to ensure that transplants are not only administered to the relevant site, but also allow the monitoring of inappropriate cellular migration to improve our understanding of stem cell migration in the context of the whole organism. Areas covered: This review provides an up to date overview of molecular imaging approaches that have been used for visualizing and tracking transplanted stem cells, in vivo. Expert opinion: It's important to emphasize that the application of molecular imaging to interrogate transplanted cells may require one or even two imaging modalities to provide a reasonable assessment of transplanted cells in specific organs.


  • Open Access

    Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: a longitudinal imaging study

    by Johanna S Jackson, Jon P Golding, Catherine Chapon, William A Jones, Kishore K Bhakoo

    Introduction: This study aimed to determine the homing potential and fate of epidermal neural crest stem cells (eNCSCs) derived from hair follicles, and bone marrow-derived stem cells (BMSCs) of mesenchymal origin, in a lipopolysaccharide (LPS)-induced inflammatory lesion model in the rat brain. Both eNCSCs and BMSCs are easily accessible from adult tissues by using minimally invasive procedures and can differentiate into a variety of neuroglial lineages. Thus, these cells have the potential to be used in autologous cell-replacement therapies, minimizing immune rejection, and engineered to secrete a variety of molecules. Methods: Both eNCSCs and BMSCs were prelabeled with iron-oxide nanoparticles (IO-TAT-FITC) and implanted either onto the corpus callosum in healthy or LPS-lesioned animals or intravenously into lesioned animals. Both cell types were tracked longitudinally in vivo by using magnetic resonance imaging (MRI) for up to 30 days and confirmed by postmortem immunohistochemistry. Results: Transplanted cells in nonlesioned animals remained localized along the corpus callosum. Cells implanted distally from an LPS lesion (either intracerebrally or intravenously) migrated only toward the lesion, as seen by the localized MRI signal void. Fluorescence microscopy of the FITC tag on the nanoparticles confirmed the in vivo MRI data, Conclusions: This study demonstrated that both cell types can be tracked in vivo by using noninvasive MRI and have pathotropic properties toward an inflammatory lesion in the brain. As these cells differentiate into the glial phenotype and are derived from adult tissues, they offer a viable alternative autologous stem cell source and gene-targeting potential for neurodegenerative and demyelinating pathologies.